Alibaba Health Information Technology Limited (TWY) - Net Assets
Based on the latest financial reports, Alibaba Health Information Technology Limited (TWY) has net assets worth €17.57 Billion EUR as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€23.26 Billion) and total liabilities (€5.70 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €17.57 Billion |
| % of Total Assets | 75.51% |
| Annual Growth Rate | 39.78% |
| 5-Year Change | 14.22% |
| 10-Year Change | N/A |
| Growth Volatility | 64.5 |
Alibaba Health Information Technology Limited - Net Assets Trend (2017–2025)
This chart illustrates how Alibaba Health Information Technology Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Alibaba Health Information Technology Limited (2017–2025)
The table below shows the annual net assets of Alibaba Health Information Technology Limited from 2017 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €16.31 Billion | +12.37% |
| 2024-03-31 | €14.52 Billion | -4.16% |
| 2023-03-31 | €15.15 Billion | +7.64% |
| 2022-03-31 | €14.07 Billion | -1.47% |
| 2021-03-31 | €14.28 Billion | +174.51% |
| 2020-03-31 | €5.20 Billion | +90.09% |
| 2019-03-31 | €2.74 Billion | +8.47% |
| 2018-03-31 | €2.52 Billion | +125.34% |
| 2017-03-31 | €1.12 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Alibaba Health Information Technology Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 241630100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.32 Billion | 8.12% |
| Other Components | €14.99 Billion | 91.88% |
| Total Equity | €16.31 Billion | 100.00% |
Alibaba Health Information Technology Limited Competitors by Market Cap
The table below lists competitors of Alibaba Health Information Technology Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Akbank TAS
IS:AKBNK
|
$9.73 Billion |
|
Sanan Optoelectronics Co Ltd
SHG:600703
|
$9.74 Billion |
|
Chubu Electric Power Company Incorporated
F:0C2
|
$9.74 Billion |
|
GAIL (INDIA) GDR/6 IR 10
F:GQI
|
$9.75 Billion |
|
Trade Desk Inc
NASDAQ:TTD
|
$9.73 Billion |
|
Qantas Airways Ltd
AU:QAN
|
$9.72 Billion |
|
Getlink SE
PA:GET
|
$9.72 Billion |
|
OGE Energy Corporation
NYSE:OGE
|
$9.71 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Alibaba Health Information Technology Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 14,544,212,000 to 16,312,179,000, a change of 1,767,967,000 (12.2%).
- Net income of 1,432,427,000 contributed positively to equity growth.
- Share repurchases of 39,931,000 reduced equity.
- New share issuances of 4,587,000 increased equity.
- Other factors increased equity by 370,884,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €1.43 Billion | +8.78% |
| Share Repurchases | €39.93 Million | -0.24% |
| Share Issuances | €4.59 Million | +0.03% |
| Other Changes | €370.88 Million | +2.27% |
| Total Change | €- | 12.16% |
Book Value vs Market Value Analysis
This analysis compares Alibaba Health Information Technology Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.51x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.59x to 0.51x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €0.14 | €0.52 | x |
| 2018-03-31 | €0.26 | €0.52 | x |
| 2019-03-31 | €0.24 | €0.52 | x |
| 2020-03-31 | €0.44 | €0.52 | x |
| 2021-03-31 | €1.06 | €0.52 | x |
| 2022-03-31 | €1.04 | €0.52 | x |
| 2023-03-31 | €1.12 | €0.52 | x |
| 2024-03-31 | €0.90 | €0.52 | x |
| 2025-03-31 | €1.01 | €0.52 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Alibaba Health Information Technology Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.78%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.68%
- • Asset Turnover: 1.44x
- • Equity Multiplier: 1.30x
- Recent ROE (8.78%) is above the historical average (-0.65%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -17.63% | -43.70% | 0.28x | 1.43x | €-325.41 Million |
| 2018 | -4.15% | -4.38% | 0.79x | 1.21x | €-365.00 Million |
| 2019 | -2.93% | -1.61% | 0.85x | 2.14x | €-361.40 Million |
| 2020 | -0.12% | -0.07% | 1.22x | 1.49x | €-533.50 Million |
| 2021 | 2.44% | 2.25% | 0.87x | 1.24x | €-1.08 Billion |
| 2022 | -1.88% | -1.29% | 1.07x | 1.36x | €-1.68 Billion |
| 2023 | 3.53% | 2.00% | 1.29x | 1.37x | €-981.72 Million |
| 2024 | 6.07% | 3.27% | 1.37x | 1.35x | €-570.94 Million |
| 2025 | 8.78% | 4.68% | 1.44x | 1.30x | €-198.79 Million |
Industry Comparison
This section compares Alibaba Health Information Technology Limited's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $16,963,069,333
- Average return on equity (ROE) among peers: -2.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Alibaba Health Information Technology Limited (TWY) | €17.57 Billion | -17.63% | 0.32x | $9.73 Billion |
| JD HEALTH INTL LTD (8ZN) | $55.24 Billion | 7.53% | 0.29x | $17.90 Billion |
| YSB Inc. (B1S) | $-4.37 Billion | 0.00% | 0.00x | $413.02 Million |
| Redcare Pharmacy NV (RDC) | $18.08 Million | -15.66% | 0.42x | $815.28 Million |
About Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family pl… Read more